In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 93350_SIGMA Drug Master File in Korea (93350_SIGMA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 93350_SIGMA. The MFDS reviews the 93350_SIGMA KDMF as part of the drug registration process and uses the information provided in the 93350_SIGMA KDMF to evaluate the safety and efficacy of the drug.
After submitting a 93350_SIGMA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 93350_SIGMA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 93350_SIGMA suppliers with KDMF on PharmaCompass.